Biomarkers for Lung Diseases: Types, Testing, and Clinical Applications

What Are Biomarkers in Lung Diseases?

Have you ever wondered how doctors can 'see' what’s happening deep inside your lungs before symptoms even show up? Biomarkers are measurable parameters in the body that help physicians assess the presence of a disease. In lung diseases, biomarkers may be detected in blood, sputum, lung tissue biopsies, or CT scans. The biomarkers may include specific proteins, genes, and cells that change in the body when one has a disease.

The use of biomarkers in lung diseases enables early detection, determination of disease nature and severity, selection of appropriate treatment, and assessment of treatment effectiveness in the patient's body. Genetic biomarkers assist in the administration of targeted treatments in lung cancers, while inflammatory biomarkers assist in diagnosing asthma and chronic lung diseases.

Why Biomarkers Matter in Lung Diseases?

Lung diseases include COPD, asthma (where airways become swollen and narrow), fibrosis (where lungs become stiff), and lung cancer. These diseases affect a person's ability to breathe. Biomarkers are small signs in the body that doctors can measure. They help doctors find these diseases, watch how they change, and understand what might happen next.

Here are some of the most important biomarkers for lung diseases:

• Functional Lung Assessment: Spirometry is a simple breathing test that checks how well your lungs work; it is not a true biomarker test. It measures FEV1 (forced expiratory volume in 1 second), which is how much air you can blow out in 1 second, and FVC, which is the total air you can blow out. Doctors use this test to find and monitor lung problems like asthma, which can sometimes make breathing hard, and COPD, a long-term lung problem that can make breathing difficult. Spirometry helps doctors know how healthy your lungs are and decide the right medicine or care to help you breathe better.

• Fractional Exhaled Nitric Oxide (FeNO): It is a simple test that helps doctors find and monitor asthma. It measures nitric oxide, a gas in your breath produced by inflamed or swollen airways. Higher levels can indicate that the lungs are irritated, so doctors can use this to assess how severe asthma is and how well treatment is working.

• Blood Eosinophils: Eosinophils are a type of white blood cell that helps the body fight allergies and inflammation. Having too many eosinophils in the blood suggests eosinophilic inflammation, which is commonly seen in some types of asthma or other allergic lung conditions.

• Imaging Tests: Imaging tests help doctors visualize the lungs to detect abnormalities. X-rays take pictures of the inside of the body. These imaging tests can reveal important signs, such as tumor size and patterns of fibrosis.

A Computed Tomography (CT) scan provides detailed X-ray images of the lungs from cross-sections, while Magnetic Resonance Imaging (MRI) uses magnets and radio waves to generate detailed images of the lungs and other parts of the body. These imaging techniques help identify any lumps, scars, or inflammation in the lungs.

• Biomarkers for Lung Cancer: Lung cancer biomarkers include genetic mutations like EGFR (epidermal growth factor receptor), ALK (anaplastic lymphoma kinase), and KRAS (Kirsten rat sarcoma viral oncogene). These mutations are found in some types of lung cancer and help doctors identify the exact type of cancer a person has. Knowing these biomarkers guides doctors to choose the most effective treatment plan for each patient.

• Blood Biomarkers: Certain substances in the blood, called biomarkers, can help doctors detect illness. These include C-reactive protein (CRP), procalcitonin, and interleukin-6 (IL-6). High levels can indicate inflammation (swelling) or an infection. Doctors use these tests to find and watch lung infections like pneumonia and see if medicine is helping.

• Breath Biomarkers: Volatile organic compounds (VOCs) are tiny chemicals in a person’s breath that tell doctors how the body is working. Breath biomarkers, such as VOCs, are being studied as potential tools but are not yet widely used in routine practice.

Types of Lung Disease Biomarkers

Here are some examples:

• Genetic Biomarkers: Genetic biomarkers are changes in DNA (deoxyribonucleic acid) or RNA (ribonucleic acid) that can indicate whether someone might develop a lung disease or how they might respond to treatment. For example, changes in the CFTR gene (cystic fibrosis transmembrane conductance regulator) can cause cystic fibrosis, and some gene patterns can show a higher chance of lung cancer. Doctors use these biomarkers to help find problems early and choose the best treatment for each person.

• Protein Biomarkers: These are specific proteins detectable in blood and lung tissue. They give doctors insights into understanding lung diseases. Protein biomarkers may reflect disease severity, progression, and the effectiveness of certain treatments. For instance, some proteins are associated with lung fibrosis, which leads to the hardening of the lungs.

• Circulating Biomarkers (Liquid Biopsy): Liquid biopsy is an easy, noninvasive technique used to detect and manage cancer. It involves analyzing the minute cancer-derived biomarkers in bodily fluids such as blood, saliva, or urine. This includes tumor-derived DNA fragments, circulating tumor cells, and extracellular vesicles. The procedure enables health practitioners to diagnose cancer at its initial stages. Then they evaluate the progression of the disease and determine the effectiveness of the therapeutic regimen. It also allows the identification of any resistance developed by the cancer to the medications administered. Unlike conventional biopsy methods, liquid biopsy does not involve invasive surgical procedures.

Biomarker Testing for Lung Diseases

The biomarker test used to diagnose lung conditions, such as cancer, involves checking genes and proteins in the tissue or blood. This will enable medical professionals to determine the appropriate course of treatment. This test plays a significant role in non-small cell lung cancer by enabling the identification of tumor characteristics.

• What Is Biomarker Testing?

If someone has non-small cell lung cancer, it is important to discuss biomarker testing with the doctor. This test checks for changes in the tumor’s DNA, RNA, and proteins to better understand the cancer. It looks for mutations that develop over time, not the ones inherited from parents. Testing DNA, RNA, and proteins together gives a complete picture of the tumor. This helps doctors choose the most suitable and effective treatment.

• How Testing Is Done?

If there are any suspicions about cancer, then the doctor will perform a tissue test, called a biopsy.

Specialists examine the specimen using a microscope to diagnose cancer and assess its nature.

In addition, specialists conduct biomarker tests on this specimen. A lung cancer blood test is performed for a liquid biopsy that helps to discover cancer or tumor DNA in the patient. This test can be used as an indicator of disease progression or recurrence after the therapy.

• When Should Testing Be Done?

Tests must be conducted at the earliest opportunity, preferably before the biopsy. This ensures sufficient tissue is available for biomarker testing and for a correct diagnosis. It is also important to repeat tests if the disease recurs or if there is no response to therapy. For example, in cases such as Non-small Cell Lung Cancer, early and timely testing will help doctors choose the right course of treatment.

Role of Biomarkers in Personalized Treatment

A biomarker is a simple indicator within the body that helps doctors diagnose diseases and determine the appropriate treatment for patients. Biomarkers play a vital role in personalized therapy by enabling doctors to select the appropriate treatment for each individual case.

Important aspects of biomarkers used in personalized medicine include:

• Predictive Biomarkers: These help doctors predict whether a treatment will benefit patients.

• Prognostic Biomarkers: They give information about the potential course of the disease or expected outcomes.

• Diagnostic and Subtype Biomarkers: They help diagnose the disease and identify its subtype.

• Monitoring and Safety Aspects: These are concerned with monitoring the effect of treatments and detecting complications.

Advantages and Limitations of Biomarkers

However, there are certain limitations associated with biomarkers when using them for diagnostic and therapeutic purposes.

Advantages

• Biomarkers aid in identifying diseases at their earliest stages, leading to better treatments.

• Biomarkers enable proper diagnosis of the type of disease.

• Tailored therapies help doctors select the best therapy for each patient.

• They can monitor the effectiveness of treatment.

• They ensure better chances of successful treatment.

Limitations

• There may be cases in which some biomarkers fail to yield accurate, reliable findings.

• More complex biomarker tests might not be readily available at some medical facilities.

• There could be cases where some tests are very expensive and inaccessible to all patients.

• To understand the results, specialized knowledge and skills are required.

• They can only complement rather than substitute other diagnostics.

When to Talk to a Doctor About Biomarker Testing

It would be best to consult the doctor regarding tumor testing before the biopsy procedure to allow the oncologist to collect sufficient samples needed to perform the biomarker tests. Another essential aspect is to request additional tests when the patient’s cancer continues to develop despite targeted therapy. During the consultation, inquire about comprehensive biomarker testing or next-generation sequencing (NGS). Comprehensive biomarker testing is highly advised for patients with non-small cell lung cancer since it can detect all genetic alterations and select the most appropriate treatment option.

Conclusion

Biomarkers are significant in the management of lung cancer because they help diagnose, categorize, and assess the severity of the cancer. Biomarkers enable doctors to select the best treatment options for patients, including immunotherapy. Biomarkers are particularly significant in diagnosing Non-small Cell Lung Cancer, as they can help identify tumor mutations. While there are some challenges with biomarkers, they remain invaluable when used alongside other diagnostic tools. Is biomarker testing right for you? Reach out to a lung specialist today to explore your options. To stay informed and seek more information about this, consult a lung specialist.

Key Takeaways

• Biomarkers aid in the early detection and diagnosis of lung-related diseases.

• They assist physicians in selecting appropriate treatment options and monitor progress.

• Biomarkers are very important in conditions such as non-small cell lung cancer, asthma, COPD, and lung fibrosis.

• They can also help predict disease progression and possible outcomes.

• Biomarkers play a vital role in improving outcomes in the management of lung disorders.